Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

They have 170MM shares authorized, per recent 10Q. The fully dilutes share count is about 51MM. Technically, they don't need to authorize new share, but they need an ability to comply with NASDAQ requirements within few months. The only way they can do that is to push the share price to over 1.00 and hold there for 10 consecutive days or more. It's hard to do if there are no catalysts. The management likely knows nothing of that scale is going to happen, thus the quick and dirty option is going to be pushed on us -- another reverse split. The proxy is expected to be out within a month, and the markets know it and they will be shorting the hell out of this stock in an anticipation of the proxy. Wash, rinse, repeat...